These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. Grbic JT, Black DM, Lyles KW, Reid DM, Orwoll E, McClung M, Bucci-Rechtweg C, Su G. J Am Dent Assoc; 2010 Nov; 141(11):1365-70. PubMed ID: 21037195 [Abstract] [Full Text] [Related]
32. Early appearance of osteonecrosis of the jaw after zoledronic acid in a patient with a long history of taking oral bisphosphonates. Uña E. BMJ Case Rep; 2012 Mar 27; 2012():. PubMed ID: 22605820 [Abstract] [Full Text] [Related]
33. Antiresorptive drug-related osteonecrosis of the jaw. Uyanne J, Calhoun CC, Le AD. Dent Clin North Am; 2014 Apr 27; 58(2):369-84. PubMed ID: 24655528 [Abstract] [Full Text] [Related]
40. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. Clin Ther; 2007 Aug 27; 29(8):1548-58. PubMed ID: 17919538 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]